Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

Quia Pharma AB (publ) (99B0.F)

Compare
0.0009
+0.0008
+(800.00%)
At close: April 4 at 10:30:19 AM GMT+2

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Dr. Vidar Wendel-Hansen M.D., Ph.D. Chief Medical Officer & Director -- -- 1959
Mr. Marcus Bosson MD, CEO & Director 2.41M -- 1968
Ms. Hjordis Berg Chief Financial Officer -- -- 1955
Dr. Supaporn Sawadjoon Head of Operations 939.87k -- 1978

Quia Pharma AB (publ)

Uppsala Business Park
Virdings Allé 32 B
Uppsala, 754 50
Sweden
46 7 06 93 12 53 https://www.quiapeg.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Corporate Governance

Quia Pharma AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
 
SIMRIS-B.ST Simris Group AB (PUBL)
0.1105
-1.34%
 
CHOSA.ST CHOSA Oncology AB
0.6680
-4.57%
 
2CUREX.ST 2cureX AB (publ)
0.3500
-6.17%
 
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
 
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1264
+6.94%
 
ALZCUR.ST AlzeCure Pharma AB (publ)
2.6100
+9.66%
 
LIDDS.ST LIDDS AB (publ)
0.0600
+55.44%
 
CRNA.OL Circio Holding ASA
0.5620
+2.18%
 
IMMU.ST Mendus AB (publ)
5.70
+2.46%